glp 1 neurodegenerative disease A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular and disorders GLP-1 Agonists Show Promise in

Beneficial effect of olive oil and its derivates: focus on hematological neoplasm

The 120 mg dose achieved 11.3% placebo-adjusted weight loss at 36 weeks, while the exploratory 240 mg dose showed up to 15.3%

Nanoparticle delivery systems for gaseous antioxidants In addition to conventional drug delivery platforms, nanoparticle delivery systems for gaseous antioxidants have demonstrated unique potential in the treatment of RIRI in recent years

Hers weight loss pros and cons While Hers is a convenient alternative to traditional healthcare, there are downsides

McGill, G

Texture, fine lines, and firmness change gradually, so baseline photographs provide a more reliable comparison than daily observation